Markets:

Overview

News

Currencies

International

Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

38.91 +0.34 (+0.87%)

Streaming Delayed Price Updated: 2:58 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2

...

22 23 24 25 26 27 28 29 Next >

2 Surging Healthcare Stocks That Are Still Worth Buying ↗

February 23, 2023

These two NASH drugmakers have a lot of room to run.

Via The Motley Fool

Viking Therapeutics's Earnings: A Preview ↗

February 07, 2023

Via Benzinga

Analyzing Viking Therapeutics's Short Interest ↗

January 03, 2023

Viking Therapeutics's (NASDAQ:VKTX) short percent of float has risen 7.17% since its last report. The company recently reported that it has 1.89 million shares sold short, which is 2.54% of all regular...

Via Benzinga

5 Most Expensive Health Care Stocks You Should Worry About ↗

January 03, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

This Stock That Tripled in 2022 Could Rocket Even Higher in 2023 ↗

December 26, 2022

Potential suitors with heaps of cash to spend are lining up to get a closer look at this company's results.

Via The Motley Fool

Here's How Much $100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today ↗

December 23, 2022

Via Benzinga

Why Did Viking Therapeutics Stock Skyrocket

December 21, 2022

VKTX stock is young but strong and they have excellent potential, particularly following successful trial results from Madrigal Pharma's recent drug trial.

Via MarketBeat

Recap: Viking Therapeutics Q3 Earnings ↗

October 26, 2022

Viking Therapeutics (NASDAQ:VKTX) reported its Q3 earnings results on Wednesday, October 26, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

Recap: Viking Therapeutics Q2 Earnings ↗

July 27, 2022

Viking Therapeutics (NASDAQ:VKTX) reported its Q2 earnings results on Wednesday, July 27, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session ↗

December 19, 2022

Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 19, 2022

Via Benzinga

FDA Lifts Clinical Hold On Viking Therapeutics' Rare Metabolic Disorder Study ↗

July 19, 2022

Via Benzinga

Is Elon Musk Stepping Down as Head of Twitter? ↗

December 19, 2022

Elon Musk is in the news Monday after the billionaire held a poll asking if he should step down as head of social media company Twitter.

Via InvestorPlace

Madrigal Pharmaceuticals, Cerevel Therapeutics And Some Other Big Stocks Moving Higher On Monday ↗

December 19, 2022

U.S. stocks traded mixed, with the Nasdaq Composite dropping around 90 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Is Cosmos Health (COSM) Stock Down 58% Today? ↗

December 19, 2022

Cosmos Health (COSM) stock is falling hard on Monday after the healthcare company's shares underwent a major rally on Friday!

Via InvestorPlace

Tesla's Bouncing, but This Nasdaq Stock Tripled Monday Morning ↗

December 19, 2022

Good news can come in different forms.

Via The Motley Fool

Why Is Viking Therapeutics (VKTX) Stock Up 67% Today? ↗

December 19, 2022

Viking Therapeutics (VKTX) stock is taking off on Monday with heavy trading without any news from the biopharmaceutical company.

Via InvestorPlace

US Stocks Slightly Lower; Nasdaq Down 100 Points ↗

December 19, 2022

U.S. stocks traded slightly lower this morning, with the Nasdaq Composite dropping around 100 points on Monday.

Via Benzinga

Why Viking Therapeutics Stock Is Moving Alongside Madrigal Pharmaceuticals Shares Today ↗

December 19, 2022

Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Monday, in sympathy with Madrigal Pharmaceuticals Inc (NASDAQ: MDGL), which announced a suc

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 19, 2022

Via Benzinga

My 3 Top Biotech Stock Picks for 2023 ↗

November 22, 2022

Biotech stocks are set to shine in 2023.

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 16, 2022

Via Benzinga

Earnings Outlook For Viking Therapeutics ↗

October 25, 2022

Viking Therapeutics (NASDAQ:VKTX) is set to give its latest quarterly earnings report on Wednesday, 2022-10-26. Here's what investors need to know before the announcement. Analysts estimate that Viking...

Via Benzinga

Earnings Scheduled For October 26, 2022 ↗

October 26, 2022

Companies Reporting Before The Bell • LG Display Co (NYSE:LPL) is projected to report quarterly loss at $0.41 per share on revenue of $4.90 billion.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 11, 2022

Gainers

Via Benzinga

Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy ↗

July 27, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Viking Therapeutics Earnings Preview ↗

July 26, 2022

Viking Therapeutics (NASDAQ:VKTX) is set to give its latest quarterly earnings report on Wednesday, 2022-07-27. Here's what investors need to know before the announcement. Analysts estimate that Viking...

Via Benzinga

Recap of Tuesday's Biotech Catalysts - End Of The Day Summary ↗

July 19, 2022

The U.S. Food and Drug Administration (FDA) has granted tentative approval to Avadel Pharmaceuticals’ (NASDAQ: AVDL) lead candidate LUMRYZ (FT218) for the treatment of excessive daytime sleepiness...

Via Benzinga

U.S. FDA Lifts Clinical Hold On Viking Therapeutics' Initial-Stage Genetic Disorder Study ↗

July 19, 2022

Viking Therapeutics (NASDAQ: VKTX) announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold placed on the clinical trial of VK0214 in patients with X-linked...

Via Benzinga

Earnings Scheduled For July 27, 2022 ↗

July 27, 2022

Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to report earnings for its second quarter.

Via Benzinga

< Previous 1 2

...

22 23 24 25 26 27 28 29 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.